Skip to main content

Inhibikase Therapeutics, Inc. - Common Stock (NQ:IKT)

1.700 -0.040 (-2.30%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jun 18, 2025 Add to My Watchlist

Price and Volume

Detailed Quote
Volume 188,985
Open 1.740
Bid (Size) 1.700 (1)
Ask (Size) 2.180 (311)
Prev. Close 1.740
Today's Range 1.695 - 1.775
52wk Range 1.120 - 4.200
Shares Outstanding N/A
Dividend Yield N/A

Performance

YTD
-48.3%
-48.3%
1 Month
-9.1%
-9.1%
3 Month
-31.2%
-31.2%
6 Month
-53.4%
-53.4%
1 Year
+14.1%
+14.1%

More News

Read More

Frequently Asked Questions

Is Inhibikase Therapeutics, Inc. - Common Stock publicly traded?
Yes, Inhibikase Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does Inhibikase Therapeutics, Inc. - Common Stock trade on?
Inhibikase Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Inhibikase Therapeutics, Inc. - Common Stock?
The ticker symbol for Inhibikase Therapeutics, Inc. - Common Stock is IKT on the Nasdaq Stock Market
What is the current price of Inhibikase Therapeutics, Inc. - Common Stock?
The current price of Inhibikase Therapeutics, Inc. - Common Stock is 1.700
When was Inhibikase Therapeutics, Inc. - Common Stock last traded?
The last trade of Inhibikase Therapeutics, Inc. - Common Stock was at 06/18/25 04:00 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.